Good news has come for people suffering from obesity. After getting approval from the Central Drugs Standard Control ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...
Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...
Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...
Newspoint on MSN22h
Weight loss drug launched in India, will reduce sagging fat, weight will reduce up to 21 kg, know the price and where to get itIn India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback